Literature DB >> 692059

Streptokinase and concomitant oral anticoagulants in the treatment of deep venous thrombosis.

P Järvinen, U Aromaa, M Roiha, K Asp.   

Abstract

Fourty-four patients with deep venous thrombosis of the leg diagnosed by phlebography and not more than five days old were treated with streptokinase. Oral anticoagulant therapy was started at the same time. Complete lysis of thrombi was obtained in 6 cases and partial one in 25 cases. Lysis of proximal thrombi was better than that of distal ones. The age of the thrombi had no effect on the lysis. Urticaria and anaphylactic reactions occurred in 8 patients and treatment was discontinued. Haemorrhagic complications were present in 8 cases but remission was obtained by dicontinuing streptokinase infusion. Commencing oral anticoagulant therapy simultaneously with streptokinase reduces duration of treatment without increasing the risks and the results of lysis are equally good as with earlier studies. The use of streptokinase is recommended in the treatment of proximal deep venous thrombosis. This treatment offers a possibility of preventing a postthrombotic syndrome. The frequency of various complications should however be borne in mind.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 692059     DOI: 10.1007/BF01489713

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  19 in total

1.  Clinical diagnosis and prognosis of deep venous thrombosis.

Authors:  P Järvinen; K Asp
Journal:  Ann Chir Gynaecol Fenn       Date:  1975

2.  The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.

Authors:  A J JOHNSON; W R McCARTY
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

3.  Is streptokinase useful in the treatment of deep vein thrombosis?

Authors:  R Bieger; R J Boekhout-Mussert; F Hohmann; E A Loeliger
Journal:  Acta Med Scand       Date:  1976

4.  Postthrombotic syndrome of the lower extremity; treatment by interruption of the superficial femoral vein and ligation and stripping of the long and short saphenous veins.

Authors:  R R LINTON; I B HARDY
Journal:  Surgery       Date:  1948-09       Impact factor: 3.982

Review 5.  [Heparin or thrombolysis in the treatment of deep venous thrombosis of the leg].

Authors:  L K Widmer; G Madar; H E Schmitt; F Duckert; M A da Silva; G Müller
Journal:  Vasa       Date:  1974       Impact factor: 1.961

6.  Streptokinase therapy in deep-vein thrombosis.

Authors:  G E Mavor; D P Dhall; A A Dawson; J S Duthie; M G Walker; R G Mahaffy; M Allardyce
Journal:  Br J Surg       Date:  1973-06       Impact factor: 6.939

7.  Deep venous thrombosis treated with a standard dosage of streptokinase.

Authors:  B Olow; C Johanson; J Andersson; B Eklöf
Journal:  Acta Chir Scand       Date:  1970

8.  Streptokinase treatment of deep venous thrombosis of the lower extremity. Clinical, phlebographic and plethysmographic evaluation of early and late results.

Authors:  E Johansson; K Ericson; S Zetterquist
Journal:  Acta Med Scand       Date:  1976

9.  Treatment of deep vein thrombosis. A trial of heparin, streptokinase, and arvin.

Authors:  V V Kakkar; C Flanc; C T Howe; M O'Shea; P T Flute
Journal:  Br Med J       Date:  1969-03-29

10.  Streptokinase and deep vein thrombosis.

Authors:  N L Browse; M L Thomas; H P Pim
Journal:  Br Med J       Date:  1968-09-21
View more
  2 in total

Review 1.  Thrombolytics: drug interactions of clinical significance.

Authors:  S Harder; U Klinkhardt
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

2.  Immunology of streptokinase in human subjects.

Authors:  K McGrath; R Patterson
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.